Directory
>
Derek Raghavan Md Facp Fracp Fasco Faaas
Derek Raghavan Md Facp Fracp Fasco Faaas
Chief Medical Officer | Perthera
Charlotte, North Carolina, United States
Derek Raghavan Md Facp Fracp Fasco Faaas
Summary
Dr. Derek Raghavan is a highly accomplished medical oncologist with a distinguished career spanning over several decades, specializing in genitourinary cancer and the development of innovative cancer treatments. He has held prominent leadership positions, including President of the Levine Cancer Institute and Chief Medical Officer at Perthera. Dr. Raghavan is recognized for his extensive contributions to cancer research, having published over 300 articles and served on various advisory committees, including the FDA Oncology Drug Advisory Committee. His commitment to improving healthcare equity and patient safety is evident in his initiatives, such as the mobile lung cancer screening program. As an associate editor for the JCO Journal of Oncology Practice, he continues to influence the field of oncology. Dr. Raghavan's educational background includes a PhD in Experimental Pathology and multiple degrees from the University of Sydney, underscoring his deep expertise in medicine and research. His leadership style is characterized by a focus on collaboration and innovation, making him a respected figure in the oncology community.
Derek Raghavan Md Facp Fracp Fasco Faaas
Work Experience
Chief Medical Officer at
Perthera
April 2024 - Present
Attending GU Medical Oncologist at
Veterans Administration Health Care Center
May 2018 - Present
President, Levine Cancer Institute, Professor of Medicine at
Atrium Health
April 2011 - January 2023
Chair & Director, Taussig Cancer Institute, Professor Medicine, Lerner College of Medicine at
Cleveland Clinic
January 2004 - January 2011
Chair, Medical Oncology & Assoc Director Norris Comprehensive Cancer Ctr, Prof. Medicine/Urology at
University of Southern California
August 1997 - February 2004
Chair & Professor, Solid Tumor Oncology/Investigational Therapeutics at
Roswell Park Comprehensive Cancer Center
January 1991 - January 1997
Staff Oncologist; Research Director, Urological Cancer Research Unit at
UNIVERSITY OF SYDNEY UNION
January 1981 - January 1991
Medical Research Specialist, Masonic Cancer Center at
Univ. of Minnesota
January 1980 - January 1981
Research fellow, Senior Registrar (Fellow), Ludwig Institute for Cancer Research at
THE ROYAL MARSDEN NHS FOUNDATION TRUST
January 1978 - January 1980
Oncology fellow at
NEW SOUTH WALES CRIME COMMISSION
January 1977 - January 1978
Intern and Resident at
NEW SOUTH WALES CRIME COMMISSION
January 1974 - January 1977
Medical Student at
UNIVERSITY OF SYDNEY UNION
January 1970 - January 1973
Derek Raghavan Md Facp Fracp Fasco Faaas
Education
University of London & Ludwig Institute for Cancer Research, Phd
The University of Sydney, Mbbs
The University of Sydney, Doctor Of Medicine (M.D.)
Frequently Asked Questions about Derek Raghavan Md Facp Fracp Fasco Faaas
What company does Derek Raghavan Md Facp Fracp Fasco Faaas work for?
Derek Raghavan Md Facp Fracp Fasco Faaas is a Chief Medical Officer at Perthera, a company specializing in Specialty hospitals, except psychiatric.
Where Derek Raghavan Md Facp Fracp Fasco Faaas graduated from?
Derek Raghavan Md Facp Fracp Fasco Faaas holds a degree in Experimental Pathology from University of London & Ludwig Institute for Cancer Research.
Is Derek Raghavan Md Facp Fracp Fasco Faaas an immigrant?
Yes, Derek Raghavan Md Facp Fracp Fasco Faaas is an immigrant and currently based in United States
Who is Derek Raghavan Md Facp Fracp Fasco Faaas?
Dr. Derek Raghavan is a highly accomplished medical oncologist with a distinguished career spanning over several decades, specializing in genitourinary cancer and the development of innovative cancer treatments. He has held prominent leadership positions, including President of the Levine Cancer Institute and Chief Medical Officer at Perthera. Dr. Raghavan is recognized for his extensive contributions to cancer research, having published over 300 articles and served on various advisory committees, including the FDA Oncology Drug Advisory Committee. His commitment to improving healthcare equity and patient safety is evident in his initiatives, such as the mobile lung cancer screening program. As an associate editor for the JCO Journal of Oncology Practice, he continues to influence the field of oncology. Dr. Raghavan's educational background includes a PhD in Experimental Pathology and multiple degrees from the University of Sydney, underscoring his deep expertise in medicine and research. His leadership style is characterized by a focus on collaboration and innovation, making him a respected figure in the oncology community.
Derek`s contact details
Colleagues
Vice President of Medical Affairs
Vice President Operations
VP of Finance
Consultant, Chair Science Advisory Board
Vice President Research